menu search

Neurona therapeutics announces publication in cell stem cell reporting the development of investigational novel regenerative cell therapy strategy for drug-resistant focal epilepsy

Publication demonstrates robust and reproducible generation of pure pallial, medial ganglionic eminence (MGE)-type GABAergic inhibitory interneuron ce...

October 5, 2023, 3:00 pm

Following up on phathom pharmaceuticals

Phathom Pharmaceuticals is a small biopharma firm focused on developing treatments for gastrointestinal diseases. The company has recently filed some ...

October 5, 2023, 12:43 pm

Moderna (mrna) to advance covid/flu combo jab to late-stage study

Moderna's (MRNA) intends to start the late-stage study on its COVID-19-influenza combination vaccine candid...

October 5, 2023, 12:02 pm

Nuvalent stock gains on lung cancer data, but i'd only buy on dip

Nuvalent, Inc. stock gained 36% and reached an all-time high of $58 per share yesterday, with a market cap valuation of $3.3bn. The biotech company is...

October 5, 2023, 11:00 am

Okyo pharma phase ii dry eye trial making encouraging progress

OKYO Pharma Ltd (NASDAQ:OKYO), the clinical-stage drug developer, has reported encouraging safety data for its ongoing phase II clinical trial of OK-1...

October 5, 2023, 7:58 am

Valneva's vaccination valor: a buy rating justified

Valneva's 1H 2023 revenue declined compared to the previous year, but product sales more than doubled, driven by the recovery in the travel market. Th...

October 4, 2023, 11:45 pm

Verastem: signs of life for a beaten-down equity

Verastem is a biotechnology company focused on developing novel agents for solid tumors, with its main candid<...

October 4, 2023, 9:00 pm

Gritstone bio announces presentations from phase 1 studies evaluating next-generation vaccine candidate for covid-19 at idweek 2023

EMERYVILLE, Calif., Oct. 04, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop t...

October 4, 2023, 8:05 pm

Sanofi (sny) signs deal to co-develop teva's ibd candidate

Sanofi (SNY) and Teva enter into a collaboration deal to co-develop and co-commercialize the latter's inflammatory bowel disease ...

October 4, 2023, 12:01 pm

Kezar (kzr) falls 10% on strategic update, reduces workforce

Kezar (KZR) falls 10% on the decision to channel resources to one clinical candidate as part of its rep...

October 4, 2023, 11:17 am

5 short squeeze candidates with catalysts for rebounds

A look at the short sale lists is always interesting because there are usually as many names worthy of buying as selling. Marketbeat.com's list of hig...

October 4, 2023, 6:20 am

Novartis (nvs) announces positive data on kidney disease drug

Novartis' (NVS) phase III study on pipeline candidate iptacopan in patients with IgAN shows superiority...

October 3, 2023, 1:32 pm

Sanofi and janssen join forces to develop e.coli vaccine, with sanofi's $175m upfront payment

Sanofi revealed Tuesday that it had entered into an agreement with Janssen for the joint development and marketing of a vaccine ...

October 3, 2023, 12:05 pm

Kinnate biopharma (knte) falls 40% in a month: here's why

Kinnate Biopharma (KNTE) plunges 40% in a month for the decision to streamline its pipeline to one clinical ca...

October 3, 2023, 11:16 am

Nrx pharma (nrxp) to initiate clinical study on nrx-101, stock up

NRx Pharma (NRXP) receives FDA clearance to begin clinical development for its lead candidate, NRX-101,...

October 3, 2023, 10:31 am

Lilly's (lly) eczema candidate lebrikizumab faces fda rejection

Lilly (LLY) gets a CRL for the eczema candidate, lebrikizumab, based on inspection findings at a third-...

October 3, 2023, 9:01 am

Clade therapeutics announces the acquisition of gadeta b.v.

Expands Clade’s pipeline and broadens its platform with:– proprietary gamma/delta (g/d) TCR universal targeting platform technology,– g/d TCR ...

October 2, 2023, 12:30 pm

3 stocks to buy in october that could soar more than 40% over the next 12 months, according to wall street

BioNTech's pipeline is loaded with promising candidates. PayPal Holdings is dirt cheap and is deliverin...

October 1, 2023, 5:52 am

3 pro-bitcoin presidential candidates around the world, from vivek ramaswamy to javier milei

Ramaswamy, Kempis and Milei are among several politicians around the world trying to push Bitcoin adoption into their countries. Read Full Story The p...

September 30, 2023, 2:44 pm

Investigation of morphic holding, inc. (morf) announced by holzer & holzer, llc

ATLANTA, Sept. 29, 2023 (GLOBE NEWSWIRE) — Holzer & Holzer, LLC is investigating whether Morphic Holding, Inc. (“Morphic” or “the Company”) ...

September 29, 2023, 9:51 pm


Search within

Pages Search Results: